← Back to Search

Decision Aid for Hypertensive Disorders of Pregnancy

N/A

Waitlist Available

Research Sponsored by University of Utah

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Ability to speak and read English or Spanish

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up one month after the initial assessment

Awards & highlights

Study Summary

This trial studied how to help women reduce their risk of future heart disease after a complicated pregnancy.

Who is the study for?

This trial is for English or Spanish-speaking women who recently gave birth at the University of Utah and had high blood pressure issues during pregnancy. It's not open to those with a history of cardiovascular diseases like heart attack or stroke, or cognitive/vision impairments that would prevent understanding the study materials.Check my eligibility

What is being tested?

The study is testing a decision aid designed to help these new mothers engage in preventive care against heart disease. Since they're at higher risk after having high blood pressure complications in pregnancy, this tool aims to guide them towards better heart health.See study design

What are the potential side effects?

Since this trial involves using a decision aid rather than medication, there are no direct medical side effects. However, participants may experience stress or anxiety when considering their future health risks and making decisions about their care.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I can speak and read English or Spanish.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ one month after the initial assessment

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~one month after the initial assessment

This trial's timeline: 3 weeks for screening, Varies for treatment, and one month after the initial assessment for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Secondary outcome measures

Decisional conflict

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Decision aidExperimental Treatment1 Intervention

Participants will use the decision aid in the postpartum period

Group II: Usual careActive Control1 Intervention

Participants will receive standard postpartum care

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

University of UtahLead Sponsor

1,098 Previous Clinical Trials

1,778,590 Total Patients Enrolled

National Heart, Lung, and Blood Institute (NHLBI)NIH

3,834 Previous Clinical Trials

47,310,595 Total Patients Enrolled

Media Library

Decision aid Clinical Trial Eligibility Overview. Trial Name: NCT05826925 — N/A

Cardiovascular Disease Research Study Groups: Decision aid, Usual care

Cardiovascular Disease Clinical Trial 2023: Decision aid Highlights & Side Effects. Trial Name: NCT05826925 — N/A

Decision aid 2023 Treatment Timeline for Medical Study. Trial Name: NCT05826925 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there openings available to participants for this research endeavor?

"According to the clinicaltrials.gov records, this medical study is no longer recruiting participants as it was last updated on April 10th 2023. Nevertheless, there are numerous alternate trials that remain open for enrollment with 1,336 presently available options."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Optimizing Cardiovascular Preventive Care for Women Following Hypertensive Disorders of Pregnancy

Lauren Theilen 2025. "Optimizing Cardiovascular Preventive Care for Women Following Hypertensive Disorders of Pregnancy". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05826925.